Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 13
1998 1
1999 1
2000 22
2001 1
2003 1
2004 1
2005 1
2006 2
2008 1
2012 5
2014 1
2016 1
2018 20
2019 353
2020 597
2021 624
2022 597
2023 589
2024 161

Text availability

Article attribute

Article type

Publication date

Search Results

2,543 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of primary aldosteronism.
Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Reincke M, et al. Lancet Diabetes Endocrinol. 2021 Dec;9(12):876-892. doi: 10.1016/S2213-8587(21)00210-2. Lancet Diabetes Endocrinol. 2021. PMID: 34798068 Free article. Review.
Advances in molecular histopathology challenge the traditional concept of primary aldosteronism as a binary disease, caused by either a unilateral aldosterone-producing adenoma or bilateral adrenal hyperplasia. Somatic mutations drive autonomous aldosterone production in m …
Advances in molecular histopathology challenge the traditional concept of primary aldosteronism as a binary disease, caused by either a unil …
Overview of the 2022 WHO Classification of Pituitary Tumors.
Asa SL, Mete O, Perry A, Osamura RY. Asa SL, et al. Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15. Endocr Pathol. 2022. PMID: 35291028 Review.
Anterior lobe tumors include (i) well-differentiated adenohypophyseal tumors that are now classified as pituitary neuroendocrine tumors (PitNETs; formerly known as pituitary adenomas), (ii) pituitary blastoma, and (iii) the two types of craniopharyngioma. ...
Anterior lobe tumors include (i) well-differentiated adenohypophyseal tumors that are now classified as pituitary neuroendocrine tumors (Pit …
Diagnosis and Management of Pituitary Adenomas: A Review.
Tritos NA, Miller KK. Tritos NA, et al. JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444. JAMA. 2023. PMID: 37097352 Review.
Clinically evident pituitary adenomas occur in approximately 1 in 1100 persons. OBSERVATIONS: Pituitary adenomas are classified as either macroadenomas (10 mm) (48% of tumors) or microadenomas (<10 mm). Macroadenomas may cause mass effect, such as visual field de …
Clinically evident pituitary adenomas occur in approximately 1 in 1100 persons. OBSERVATIONS: Pituitary adenomas are classifie …
Acromegaly: pathogenesis, diagnosis, and management.
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Fleseriu M, et al. Lancet Diabetes Endocrinol. 2022 Nov;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3. Epub 2022 Oct 6. Lancet Diabetes Endocrinol. 2022. PMID: 36209758 Review.
Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells and are usually sporadic. ...
Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells …
Clinical Biology of the Pituitary Adenoma.
Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY. Melmed S, et al. Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010. Endocr Rev. 2022. PMID: 35395078 Free PMC article. Review.
It is estimated that fewer than one-thousandth of all pituitary adenomas cause clinically significant disease. Adenomas variably and adversely affect morbidity and mortality depending on cell type, hormone secretory activity, and growth behavior. For most clinically …
It is estimated that fewer than one-thousandth of all pituitary adenomas cause clinically significant disease. Adenomas variab …
Pathways of Colorectal Carcinogenesis.
Nguyen LH, Goel A, Chung DC. Nguyen LH, et al. Gastroenterology. 2020 Jan;158(2):291-302. doi: 10.1053/j.gastro.2019.08.059. Epub 2019 Oct 14. Gastroenterology. 2020. PMID: 31622622 Free PMC article. Review.
We review the genetic changes associated with the development of precancerous colorectal adenomas and their progression to tumors, as well as the effects of defective DNA repair, chromosome instability, microsatellite instability, and alterations in the serrated pathway an …
We review the genetic changes associated with the development of precancerous colorectal adenomas and their progression to tumors, as …
Risk Factors for Colorectal Polyps and Cancer.
Sninsky JA, Shore BM, Lupu GV, Crockett SD. Sninsky JA, et al. Gastrointest Endosc Clin N Am. 2022 Apr;32(2):195-213. doi: 10.1016/j.giec.2021.12.008. Epub 2022 Feb 22. Gastrointest Endosc Clin N Am. 2022. PMID: 35361331 Review.
Most CRC cases arise from precancerous adenomatous and serrated polyps. Established risk factors for conventional adenomas and CRC include age, male sex, family history, obesity and physical inactivity, and red meat intake. White race and tobacco and alcohol use are import …
Most CRC cases arise from precancerous adenomatous and serrated polyps. Established risk factors for conventional adenomas and CRC in …
The Epidemiology of Pituitary Adenomas.
Daly AF, Beckers A. Daly AF, et al. Endocrinol Metab Clin North Am. 2020 Sep;49(3):347-355. doi: 10.1016/j.ecl.2020.04.002. Epub 2020 Jun 10. Endocrinol Metab Clin North Am. 2020. PMID: 32741475 Review.
Pituitary adenomas are usually nonmalignant, but have a heavy burden on patients and health care systems. ...Most new cases diagnosed are prolactinomas and nonsecreting pituitary adenomas. Most clinically relevant pituitary adenomas occur in females, but pitu …
Pituitary adenomas are usually nonmalignant, but have a heavy burden on patients and health care systems. ...Most new cases diagnosed …
Cushing's disease.
Ferriere A, Tabarin A. Ferriere A, et al. Presse Med. 2021 Dec;50(4):104091. doi: 10.1016/j.lpm.2021.104091. Epub 2021 Oct 27. Presse Med. 2021. PMID: 34718112 Review.
Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management.
Myers L, Ahn J. Myers L, et al. Clin Liver Dis. 2020 Aug;24(3):389-403. doi: 10.1016/j.cld.2020.04.013. Epub 2020 Jun 3. Clin Liver Dis. 2020. PMID: 32620279 Review.
Focal nodular hyperplasia and hepatocellular adenoma are benign liver lesions that occur most frequently in women and may be found as incidental findings on imaging. hepatocellular adenomas may be infrequently associated with malignant progression or risk of rupture …
Focal nodular hyperplasia and hepatocellular adenoma are benign liver lesions that occur most frequently in women and may be found as …
2,543 results